COMPANY
Ascendis Pharma Bone Diseases A/S
Ascendis Pharma Bone Diseases A/S: marketing authorisation holder for Teriparatide, as stated by public registers.
Also written as: ASCENDIS PHARMA BONE DISEASES A/S.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Teriparatide | Yorvipath (EMEA/H/C/005934), Authorised Regulator EMA |
|---|---|
| Teriparatide | YORVIPATH 168 MICROGRAMS/0.56 ML SOLUTION FOR INJECTION IN PRE FILLED PEN, PLGB 51127/0001, Authorised Regulator MHRA |
| Teriparatide | YORVIPATH 294 MICROGRAMS/0.98 ML SOLUTION FOR INJECTION IN PRE FILLED PEN, PLGB 51127/0002, Authorised Regulator MHRA |
| Teriparatide | YORVIPATH 420 MICROGRAMS/1.4 ML SOLUTION FOR INJECTION IN PRE FILLED PEN, PLGB 51127/0003, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.